Učitavanje...
Statin tolerability: In defence of placebo-controlled trials
BACKGROUND: Statin intolerance is a barrier to effective lipid-lowering treatment. A significant number of patients stop prescribed statins, or can take only a reduced dose, because of adverse events attributed to the statin, and are then considered statin-intolerant. METHODS: Examination of differe...
Spremljeno u:
| Izdano u: | Eur J Prev Cardiol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847124/ https://ncbi.nlm.nih.gov/pubmed/26318980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2047487315602861 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|